News & Media
Press Releases
Bloom Science Raises USD $12 Million in Series A Financing
Bloom Science is developing novel engineered and rationally selected microbiome-based treatments for neurological and inflammatory diseases with initial programs in Drug Resistant Epilepsy and...
The ALS Association Awards Bloom Science to Develop Novel Gut Microbiota-based Therapies for Amyotrophic Lateral Sclerosis
Bloom Science, a biopharmaceutical company focused on the discovery and development of medicines tailored for individual patients living with neurological diseases, has received a $500,000 grant...
Bloom Science Launches to Develop Neuroprotective Epilepsy Treatments in Orphan Indications with Exclusive Technology License from UCLA
Study published in Cell demonstrates causal link between seizure susceptibility and the microbiome, identifies gut bacteria that confer anti-seizure effects Bloom Science, a biotechnology company...